ADC Therapeutics SA Total Assets 2019-2022 | ADCT
ADC Therapeutics SA total assets from 2019 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
ADC Therapeutics SA Annual Total Assets
(Millions of US $) |
| 2022 |
$529 |
| 2021 |
$618 |
| 2020 |
$514 |
| 2019 |
$138 |
| 2018 |
$151 |
ADC Therapeutics SA Quarterly Total Assets
(Millions of US $) |
| 2022-12-31 |
$529 |
| 2022-09-30 |
$532 |
| 2022-06-30 |
$520 |
| 2022-03-31 |
$582 |
| 2021-12-31 |
$618 |
| 2021-09-30 |
$638 |
| 2021-06-30 |
$464 |
| 2021-03-31 |
$462 |
| 2020-12-31 |
$514 |
| 2020-09-30 |
$522 |
| 2020-06-30 |
$374 |
| 2020-03-31 |
$0 |
| 2019-12-31 |
$0 |
| 2019-09-30 |
$0 |
| 2019-06-30 |
$0 |
| 2018-12-31 |
$151 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.153B |
$0.210B |
|
ADC Therapeutics SA is a late clinical-stage oncology-focused biotechnology company. It engages in development and commercialization of antibody drug conjugates for patients suffering from hematological malignancies and solid tumors. ADC Therapeutics SA is based in LAUSANNE, Switzerland.
|
